Atwood & Palmer Inc. Trims Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Atwood & Palmer Inc. reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 25.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 520 shares of the biotechnology company’s stock after selling 180 shares during the quarter. Atwood & Palmer Inc.’s holdings in Axon Enterprise were worth $309,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Groupama Asset Managment purchased a new stake in Axon Enterprise in the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise in the third quarter valued at approximately $120,553,000. International Assets Investment Management LLC bought a new position in Axon Enterprise in the third quarter worth approximately $871,860,000. Westfield Capital Management Co. LP increased its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. raised its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AXON. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last three months. 5.70% of the stock is owned by insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $593.89 on Tuesday. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The company has a market cap of $45.28 billion, a PE ratio of 153.46, a P/E/G ratio of 5.95 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a 50-day simple moving average of $616.92 and a two-hundred day simple moving average of $463.24.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.